Skip to main content
Clinical Trials/NCT04308499
NCT04308499
Terminated
Not Applicable

Pilot Randomized Controlled Trial of Digital Cognitive-Behavioral Therapy for Insomnia in HIV-Infected Individuals

University of California, Los Angeles1 site in 1 country24 target enrollmentMarch 1, 2020
ConditionsInsomnia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insomnia
Sponsor
University of California, Los Angeles
Enrollment
24
Locations
1
Primary Endpoint
Change in Sleep Efficiency
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Insomnia is very common, especially in HIV population (up to 73%), and contributes to the development of other conditions such as depression, dementia, inflammation, obesity, and heart diseases. Cognitive-behavioral therapy for insomnia (CBT-I) is known to improve insomnia. However, it has never been tested in HIV-positive patients. The investigators aim to examine the Internet version of this therapy in HIV-positive patients because the availability of CBT-I is very limited while the cost is high. The investigators will test this internet version, also called digital CBT-I (dCBTI), against sleep hygiene education (SHE), a commonly prescribed set of instructions in clinical practice, in 60 HIV-positive patients with insomnia invited from the Multicenter AIDS Cohort Study (MACS) Los Angeles site. The investigators aim to test if dCBTI or SHE improves insomnia in this patient group. This trial involves a behavioral treatment that can be done from home with minimal side effects and includes neither medications nor invasive interventions. Lastly, this trial will provide important pilot data for a larger trial testing long-term effects of insomnia treatment in HIV-positive patients.

Registry
clinicaltrials.gov
Start Date
March 1, 2020
End Date
February 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joshua Hyong-Jin Cho

Associate professor

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • DSM-5 diagnosis of insomnia disorder
  • Aged 18 years or older
  • Reliable Internet access using either computer or smartphone
  • Ability to read and understand English

Exclusion Criteria

  • High risk of obstructive sleep apnea
  • Diagnosis of restless legs syndrome
  • Severe health issues requiring hospital admission
  • Currently receiving psychological treatment for insomnia
  • Reporting current suicidal ideation

Outcomes

Primary Outcomes

Change in Sleep Efficiency

Time Frame: Weeks 0, 4, 8, and 24

Change in sleep efficiency estimated using sleep diary with higher percentages indicating better outcome (range 0-100%)

Change in Insomnia Severity Index (ISI)

Time Frame: Weeks 0, 4, 8, and 24

Change in insomnia severity assessed by a scale with higher scores indicating worse outcome (range 0-28)

Secondary Outcomes

  • Change in Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF)(Weeks 0, 4, 8, and 24)
  • Change in Total Sleep Time (TST)(Weeks 0, 4, 8, and 24)
  • Change in Center for Epidemiologic Studies Depression Scale (CES-D)(Weeks 0, 4, 8, and 24)
  • Change in Snaith-Hamilton Pleasure Scale (SHAPS)(Weeks 0, 4, 8, and 24)
  • Change in Generalized Anxiety Disorder 7-item scale (GAD-7)(Weeks 0, 4, 8, and 24)
  • Change in Insomnia Caseness(Weeks 0, 4, 8, and 24)
  • Change in UCLA Loneliness Scale (ULS)(Weeks 0, 4, 8, and 24)
  • Change in Epworth Sleepiness Scale (ESS)(Weeks 0, 4, 8, and 24)

Study Sites (1)

Loading locations...

Similar Trials